Merck KGaA's Roemer sees possible sale of generic ops as 'right step' |
|
|
|
Published
:
Fri, 27 Apr 2007 09:48
|
FRANKFURT (Thomson Financial) - Merck KGaA's CEO Michael Roemer said he sees the possible sale of the company's generics business as a step in the right direction.'We aim to guarantee the company's future in growth markets using innovation. Mass market drugs were never one of Merck's goals, which is why the possible sale of the generics business into a consolidating market could be a step in the right direction for the future of the company,' Roemer said at the company's annual general meeting in Darmstadt.He added however that Merck is still in the process of assessing its options, and has not come to a final decision on whether or not to sell the division.krysia.diver@thomson.comkd/bsdCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Mergers and acquisitions highlights to 09:20 GMT 